Back in May 2015, we wrote an article in Dispatches asking for volunteers to join the HI-Light Vitiligo Trial. This trial was testing two different treatments for vitiligo: home UVB-light therapy (using a small, portable device that could be used at home) and a topical corticosteroid ointment (mometasone furoate 0.1%). There was a lot of interest in the trial and our recruitment target of 517 participants was achieved in September 2017. Since then, we have been continuing to monitor each of the study participants to see how they get on with the treatments and whether their skin colour has returned. This assessment phase will be completed at the end of 2018, when we will start to analyse the results. This means that we should be able to share the results of the HI-Light Vitiligo Trial with you towards the end of 2019.
In the meantime, we thought it might be worth explaining about the possible outcomes of the trial and what that might mean for people with vitiligo. In the HI-Light trial, we had four main questions that we wanted to answer:
Become a member to continue reading this article and support The Vitiligo Society
The VitLife is an online magazine and community for those dealing with vitiligo. Members get access to premium content, early bird registration to events, and special discounts with our great partners.Become a member
Already a member? Sign in